No Data
No Data
A Look At The Fair Value Of Canature Health Technology Co., Ltd. (SZSE:300272)
A-share midday announcement collection
Canature health technology: the company will change the source of the "Canature Convertible Bonds" from "newly added shares" to "prior use of repurchased shares, with any shortfall made up with newly added shares for conversion". The current conversion price is 5.47 yuan per share, and the conversion period is from January 26, 2024 to July 19, 2029. The effective date of repurchased shares as a source of conversion is September 4, 2024.
Canature Health Technology (300272.SZ): The source of convertible bond to equity swaps will be changed to prioritize the use of repurchased shares.
Canature Health Technology (300272.SZ) announced that the source of the conversion of "Canature Convertible Bonds" will be "newly added shares"...
Kaineng Health: 2024 Semi-Annual Report Summary
Kaineng Health: Semi-Annual Report 2024
Canature Health Technology (300272.SZ): The profit in the first half of the year was 57.0318 million yuan, a year-on-year increase of 6.04%.
On August 27, Canature Health Technology (300272.SZ) released its 2024 interim report, with the company's revenue for the reporting period at 829 million yuan, a year-on-year increase of 4.23%; the net income attributable to shareholders of the listed company was 57.0318 million yuan, a year-on-year increase of 6.04%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 54.1168 million yuan, a year-on-year increase of 6.05%; and the basic earnings per share was 0.10 yuan/share. It plans to distribute a cash dividend of 0.5 yuan (including tax) per 10 shares to all shareholders.
No Data
No Data